SCHEDULE: Sanara MedTech Filing: Zero Beneficial Ownership Reported

Sanara MedTech Inc. has filed a Schedule 13G amendment indicating zero beneficial ownership for reporting persons Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC.

Summary

• Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC have filed an amendment to Schedule 13G for Sanara MedTech Inc.
• Both entities report zero shares beneficially owned, zero sole voting power, zero shared voting power, zero sole dispositive power, and zero shared dispositive power.
• This filing indicates that neither reporting person holds any ownership stake or control over Sanara MedTech Inc. as of the filing date.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as having a very low sentiment score due to the complete absence of beneficial ownership reported, indicating no positive investment or strategic interest from the reporting entities.

Negatives

• Reporting persons Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC hold 0.0% of the class of securities, indicating no investment or influence.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. The absence of any reported beneficial ownership by these entities suggests a lack of significant institutional interest or a change in their prior holdings.

Stakeholder Impact

• Shareholders may view the lack of reported beneficial ownership by these entities as a sign of no new institutional support or potential future investment activity from them.

Key Dates

Keywords

Sanara MedTech, Schedule 13G, Beneficial Ownership, Investment Holding, Securities Filing